InvestorsHub Logo

devil dog 96

01/24/17 1:40 AM

#11965 RE: devil dog 96 #11963

Our new CEO for TRON. https://www.facebook.com/rene.morentin

$HIRU

DD_dempsey

01/24/17 8:57 AM

#11981 RE: devil dog 96 #11963

Thank you kindly Devildog 96- it takes a village!

And we're building a great strong village with $TRON

There is no denying the wait was LONG here. But it appears, based on a court document in Utah that we are now set for something very very awesome our way. VICTORY for TRON and now the green light to push forward with a fantastic popular new proprietary technology needed across myriad industries.

Further, The liquidity that was created by those selling shares they held for awhile, has already set us straight forward run to .03-.05 PPS.

This could go much other with the right FILINGS and the RIGHT NEWS...both of which, my DD suspects may be coming this way very very very soon.

to find some solid DD on $TRON. http://investorshub.advfn.com/THE-SUPER-SIX-31721/

$TRON & Rene Ortiz Morentin (New CEO)

https://www.linkedin.com/in/rene-morentin-aa16764

Mr. Morentin is primarily responsible for investment banking activities, which includes mergers and acquisitions, private placements, senior debt financings, and Latin American ventures. Mr. Morentin has spent his entire business career in the investment banking, merchant banking and commercial banking fields. Mr.Morentin has structured and obtained financing on leveraged buy-out transactions such as: (aggregately over $1B)

Hammermill Paper Company ($500 million);
Lorimar Telepictures Corp. ($300 million);
Cluett-Peabody, Inc. ($165 million);
Pandick Press Company ($150 million);
Princeville Development Corp. ($70 million);
Northwest Airlines ($50 million);
Carlos Murphys Restaurants, Inc. ($18 million);
American Restaurants Group ($255 million);
The Wright Companies, Inc.($15 million);
California Sports, Inc../Dr. Jerry H. Buss ($40 million).

Additionally, Mr.Morentin has arranged initial senior debt capital for The Bho-Ngam Resort Co.,Bangkok, Thailand ($50 million), and McNall Entertainment, Inc., film production financing ($40million).

Prior to founding Pantheon, Mr.Morentin has served as Managing Director of The Kensington Group, a Los Angeles-based investment banking firm; a Vice President of Manufacturers Bank (1992- 1994); Senior Vice President at Trafalgar Holdings, Ltd., a Los Angeles-based merchant bank specializing in mergers and acquisitions and off-shore project finance (1987-1989); Partner at Trafalgar Partners (1997-1989); Corporate and Institutional Services Emerging Growth Group, Merrill Lynch (1985-1986); and with The Bank of America in Corporate Banking (1981- 1983).

http://9595wg.wix.com/95952#!partners

http://www.otcmarkets.com/stock/TRON/profile

Rene Morentin’s background fits very well into the plans Toron, Inc (TRON) to merge into the healthcare space via iMedScan Corporation.

http://www.otcmarkets.com/ajax/showNewsReleaseDocumentById.pdf?id=21784

MIAMI BEACH, FLORIDA – August 17, 2016 - Toron, Inc (OTC Pink: TRON) provided its stockholders today with a corporate update regarding the pending merger with private company, iMedScan Corporation. Pursuant to the definitive Agreement and Plan of Merger entered into on March 30, 2016 iMedScan will become public through an alternative public offering or “APO” transaction with Toron.

On March 30, 2016, Toron, Inc. entered into an definitive Agreement and Plan of Merger
with iMedScan corporation, pursuant to which, upon closing, iMedScan will become a
wholly-owned subsidiary of Toron.

iMedscan Corporation is an innovative disruptive healthcare technology company
focused on integrating access to electronic data interfaces (“EDI”) for healthcare
providers and payor systems in a user friendly manner. iMedScan’s technology provides
ease of use for patients by simplifying their check-in registration process, while at the
same time reducing the healthcare providers’ administrative expenses and lost revenues
by eliminating insurance rejections, denials or any incorrect results arising from
erroneous or incomplete patient information verification. iMedScan’s proprietary
iMedScan Connect and iMedScan EDI technologies will combine to create strong,
recurring revenue for the company.

1234zxcv

01/24/17 11:46 AM

#12023 RE: devil dog 96 #11963

Seasoned traders LOVE...TRON